BioLineRx In-Licenses BL-8040 for the Treatment of AML

News   Jan 16, 2013

 
BioLineRx In-Licenses BL-8040 for the Treatment of AML
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE